|
Volumn 360, Issue 10, 2009, Pages
|
Rosuvastatin in patients with elevated C-reactive protein.
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
BLOOD;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
HUMAN;
KAPLAN MEIER METHOD;
METABOLISM;
MORTALITY;
NOTE;
RISK;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
CAUSE OF DEATH;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
KAPLAN-MEIERS ESTIMATE;
PYRIMIDINES;
RISK;
SULFONAMIDES;
|
EID: 61849173033
PISSN: None
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (5)
|
References (0)
|